Elevated exosomal Rmrp levels in serum and BALF were strongly associated with impaired AM immune responses and poor clinical outcomes in patients with sepsis, suggesting that exosomal Rmrp could serve as a biomarker for SII and secondary pneumonia. Here, RMRP is linked to susceptibility to pneumonia measurement.